Bycatch in longline fisheries is believed to govern the adverse conservation status of many seabird species, but no comprehensive global assessment has been undertaken. We reviewed the extent of seabird bycatch in all longline fisheries for which data are available. Despite the many inadequacies and assumptions contained therein, we estimated that at least 160 000 (and potentially in excess of 320 000) seabirds are killed annually. Most frequently caught are albatrosses, petrels and shearwaters, with current levels of mortality liable to be unsustainable for some species and populations. Where realistic comparisons can be made, with data from the 1990s, there is evidence of substantially reduced bycatch in some key fisheries. Reductions stem from decreased fishing effort (especially in illegal, unreported and unregulated fishing in the Southern Ocean), and greater and more effective use of technical mitigation measures, notably in demersal fisheries. However, bycatch problems in other fisheries have also emerged. Current concerns include those with previously unidentified bycatch problems (e.g. Spanish Gran Sol demersal fleet) and those where bycatch was identified, but where persistent data gaps prevented adequate assessments of the scale of the impact (e.g. Nordic demersal fisheries). Future assessments will only achieve greater precision when minimum standards of data collection, reporting and analysis are implemented by longline fishing fleets and the relevant regional fishery management organisations. Those fisheries in which bycatch has been substantially reduced demonstrate that the problem of seabird bycatch could be reduced to negligible proportions by enforced implementation of appropriate best-practice mitigation devices and techniques.
We use information on the at-sea distribution of radio-tagged seals to identify the summer foraging areas used by 31 harbour seals from two different haul-out sites in the Moray Firth, N.E. Scotland. We then determine whether seals tend to occur over particular sediment types or water depths as hypothesized by Ha Èrko È nen (1987b), and assess whether local geographical variations in diet composition can be related to local differences in available foraging habitat.The majority of seals foraged within 30 km of their haul-out site, consequently there was broad overlap between the foraging areas used by animals from the same site, but little overlap in the areas used by seals from different sites. Most seals foraged in water depths of 10±50 m with mainly sandy sea-bed sediments. Data on the distribution of dive depths of ®ve seals which were ®tted with time-depth-recorders indicated that seals were generally diving on, or close to, the sea-bed. Occasional pelagic dives between the more common benthic dives were also observed. Between-site differences in the seals' use of different water depths and sea-bed sediments suggest that local geographical variations in diet were related to local differences in foraging habitats, but that habitat use also differed between individual seals.
Marine Spatial Planning (MSP) is becoming a key management approach throughout the world. The process includes the mapping of how humans and wildlife use the marine environment to inform the development of management measures. An integrated multi-species approach to identifying key areas is important for MSP because it allows managers a global representation of an area, enabling them to see where management can have the most impact for biodiversity protection. However, multi-species analysis remains challenging. This paper presents a methodological framework for mapping key areas for marine megafauna (seabirds, pinnipeds, cetaceans) by incorporating different data types across multiple species. The framework includes analyses of tracking data and observation survey data, applying analytical steps according to the type of data available during each year quarter for each species. It produces core-use area layers at the species level, then combines these layers to create megafauna core-use area layers. The framework was applied in the Falkland Islands. The study gathered over 750,000 tracking and at-sea observation locations covering an equivalent of 5,495 data days between 1998 and 2015 for 36 species. The framework provides a step-by-step implementation protocol, replicable across geographic scales and transferable to multiple taxa. R scripts are provided. Common repositories, such as the Birdlife International Tracking Database, are invaluable tools, providing a secure platform for storing and accessing spatial data to apply the methodological framework. This provides managers with data necessary to enhance MSP efforts and marine conservation worldwide.
Tuberculosis (TB) is the deadliest infectious disease, and yet accurate diagnostics for the disease are unavailable for many subpopulations. In this study, we investigate the possibility of using human breath for the diagnosis of active TB among TB suspect patients, considering also several risk factors for TB for smokers and those with human immunodeficiency virus (HIV). The analysis of exhaled breath, as an alternative to sputum-dependent tests, has the potential to provide a simple, fast, non-invasive, and readily available diagnostic service that could positively change TB detection. A total of 50 individuals from a clinic in South Africa were included in this pilot study. Human breath has been investigated in the setting of active TB using the thermal desorption-comprehensive two-dimensional gas chromatography-time of flight mass spectrometry methodology and chemometric techniques. From the entire spectrum of volatile metabolites in breath, three machine learning algorithms (support vector machines, partial least squares discriminant analysis, and random forest) to select discriminatory volatile molecules that could potentially be useful for active TB diagnosis were employed. Random forest showed the best overall performance, with sensitivities of 0.82 and 1.00 and specificities of 0.92 and 0.60 in the training and test data respectively. Unsupervised analysis of the compounds implicated by these algorithms suggests that they provide important information to cluster active TB from other patients. These results suggest that developing a non-invasive diagnostic for active TB using patient breath is a potentially rich avenue of research, including among patients with HIV comorbidities.
South Africa is a country with a high incidence of tuberculosis (TB), complicated by coinfection with human immunodeficiency virus (HIV). The Xpert MTB/RIF (Cepheid, Sunnyvale, CA, USA) is used in South Africa as the test for the initial diagnosis of TB, and other molecular platforms such as the m2000 (Abbott Molecular, Des Plaines, IL, USA) are widely used for molecular monitoring of HIV load. The latter platform is now also equipped with the RealTime (RT) MTB and RealTime MTB RIF/INH assays for TB and first-line drug resistance screening but has not been evaluated in settings of HIV and TB coinfection. A prospective clinical validation study was conducted at a community health center in Johannesburg, South Africa, and consenting individuals with presumptive pulmonary TB were enrolled. The performance of the Abbott assays was compared with those of the Xpert MTB/RIF, liquid culture, drug susceptibility testing, and clinical case definitions. A statistical analysis was performed on 206 individuals (73% were HIV positive). The sensitivity and specificity of the RT MTB were 82.5% (confidence interval [CI], 67.2 to 92.7) and 93.1% (CI, 86.2 to 97.2) on raw sputum and 77.5% (CI, 61.5 to 89.2) and 95.1% (CI, 88.9 to 98.4) on concentrated sputum, respectively, compared with those from liquid culture. The RT MTB correctly identified 17/35 more smear-negative culture-positive specimens than the Xpert MTB/RIF. Both the RT MTB and the Xpert MTB/RIF displayed sensitivities Ͼ70% and specificities Ͼ90% in HIV-positive individuals. The available drug resistance results concurred with MTBDRplus and drug susceptibility profiles. The RT MTB assay has similar diagnostic performance to the Xpert MTB/RIF and is suited to testing presumptive TB patients coinfected with HIV. The existing laboratory information system connectivity, training, and technical support make this a viable polyvalent option to scale up TB alongside HIV laboratory testing services in South Africa.
Due to its high spatial resolution, broad spatial coverage, and cost-eVectiveness, commercial satellite imagery is rapidly becoming a key component of biological monitoring in the Antarctic. While considerable success in surveying emperor penguins (Aptenodytes forsteri) has been facilitated by their large size and the visual simplicity of their habitat, there has been considerably less progress in mapping colonies on the Antarctic Peninsula and associated sub-Antarctic islands where smaller penguin species breed on topographically complex terrain composed of mixed substrates. Here, we demonstrate that Adélie penguin (Pygoscelis adeliae), chinstrap penguin (P. antarcticus), gentoo penguin (P. papua), and macaroni penguin (Eudyptes chrysolophus) colonies can be detected by high-resolution (2-m multispectral, 40-50-cm panchromatic) satellite imagery and that under ideal conditions, such imagery is capable of distinguishing among groups of species where they breed contiguously. To demonstrate the potential for satellite imagery to estimate penguin population abundance, we use satellite imagery of Paulet Island (63°35ЈS, 55°47ЈW) to estimate a site-wide population of 115,673 (99,222-127,203) breeding pairs of Adélie penguins.
BackgroundIn 2011, South Africa improved its ability to test for rifampicin-resistant TB (RR-TB) by introducing GeneXpert MTB/RIF. At the same time, the South African National TB program adopted a policy decentralized, outpatient treatment for drug resistant (DR-) TB. We aim to analyze the impact of these changes on linkage to care and DR-TB treatment outcomes.MethodsWe retrospectively matched adult patients diagnosed with laboratory-confirmed RR-TB in Johannesburg from 07/2011–06/2012 (early cohort) and 07/2013–06/2014 (late cohort) with records of patients initiating DR-TB treatment at one of the city’s four public sector treatment sites. We determine the proportion of persons diagnosed with RR-TB who initiated DR-TB treatment and report time to treatment initiation (TTI) before and after the implementation of Xpert MTB/RIF roll-out in Johannesburg, South Africa. We conducted a sub-analysis among those who initiated DR-TB treatment at the decentralized outpatient DR-TB centers to determine if delays in treatment initiation have a subsequent impact on treatment outcomes.ResultsFive hundred ninety four patients were enrolled in the early cohort versus 713 in the late cohort. 53.8 and 36.8% of patients were diagnosed with multi-drug resistant TB in the early and late cohorts, respectively. The proportion of RR-TB confirmed cases diagnosed by Xpert MTB/RIF increased from 43.4 to 60.5% between the early and late cohorts, respectively. The proportion who initiated treatment increased from 43.1% (n = 256) to 60.3% (n = 430) in the late cohort. Pre-treatment mortality during the early and the late cohort reduced significantly from 17.5 to 5.8% while lost to follow-up remained high.Although TTI reduced by a median of 19 days, from 33 days (IQR 12–52) in the early cohort to 14 days (IQR 7–31) in the late cohort, this did not translate to improved treatment outcomes and we found no difference in terms of treatment success or on-treatment mortality for those that initiated without delay vs. those that deferred initiation.ConclusionPre-treatment mortality reduced significantly during late Xpert MTB/RIF coverage but there was no significant difference after treatment was initiated. Despite improvements there is still a significant diagnosis and treatment gap for patients diagnosed with RR-TB and improving treatment outcomes remains critical.Electronic supplementary materialThe online version of this article (10.1186/s12913-018-3762-x) contains supplementary material, which is available to authorized users.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.